Made with ❤️ by True Sparrow

Bringing you the latest funding data

SENISCA

Last funding round

Raised
$4,700,000
Round
Unknown

Funding News (2)

Mar 18 2024BioSpace

Startup details

SENISCA

SENISCA

SENISCA is an award-winning biotechnology company focused on modulating RNA biology to treat age-related diseases. The company has developed a proprietary technology that harnesses RNA biology to reprogram aged 'senescent' cells, targeting multiple age-related diseases including those of the eyes, lungs, joints, and brain.
www.senisca.com
Exeter, Devon, United Kingdom
Established in 2020
11-50 People
Healthcare, Therapeutics

Founders

Dr. Sarah Cole

Dr. Sarah Cole

CEO

Ex: TranSINE Therapeutics, Takeda Ventures, Inc. (TVI), Takeda Cambridge Neuroscience, Takeda Cambridge, Northwestern University, Feinberg School of Medicine, Northwestern University, GlaxoSmithKline, GIAP, SmithKline Beecham

Cambridge, England, United Kingdom

Investment details

Total Funding
$9,000,000
Raised
$4,700,000
Round
Unknown
Investors
Apex Ventures
QantX
Emerging Longevity Ventures
R42 Group
Lifespan Vision Ventures

Funding News (1)

Mar 18 2024FinSMEs

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Spectrum.Life raised $18.3M from ACT Venture Capital and 1 other
London-based Spectrum.Life delivers digital health and wellbeing solutions to organizations and individuals.
Spectrum.Life

Founders

Stuart McGoldrick,

Stephen Costello

In News

FinSMEs
Silicon Canals
Tech.eu
2

3 days ago

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
3

4 days ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
4

4 days ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
5

5 days ago

Praktika raised a $32.5M Series A led by Blue Wire Capital
London-based Praktika delivers AI-powered language learning with personalized avatars.

Founders

Carles Reina,

Adam Turaev

In News

FinSMEs
Tech Funding News
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.